Used primarily in pharmaceutical research as a key intermediate in the synthesis of immunomodulatory drugs. It exhibits activity in targeting cereblon, a protein involved in ubiquitin-mediated protein degradation, making it valuable in developing treatments for autoimmune diseases and certain cancers, particularly multiple myeloma. Its structure supports high binding affinity to biological targets, enhancing potency in drug candidates. Also employed in structure-activity relationship (SAR) studies to optimize pharmacokinetic properties of novel therapeutics.